Presented at the Annual Meeting of the American Academy of Otolaryngology–Head and Neck Surgery, Los Angeles, CA, September 25-28, 2005.
Objectives
The purpose of this study was to review the clinico-pathologic findings and outcome of patients with metastasis to the parotid lymph nodes and gland.
Methods
Retrospective study. Thirty-four out of 520 patients with a parotid mass treated at our institution met the criteria for this study. Age, gender, clinical findings, histopathology, treatment. and outcome were analyzed.
Results
Twenty-three patients had metastases to parotid lymph nodes from a squamous cell carcinoma of the skin, seven from a cutaneous malignant melanoma after a mean interval of 15 months, two from a ductal breast carcinoma, one with a metastatic disease from a rhabdomyosarcoma of the lower limb, and one from a Merkel cell carcinoma. The 5-year cause-specific and absolute survival for squamous cell carcinoma was 64% and 48% respectively and 71% and 57% for malignant melanomas.
Conclusions
Metastatic disease to the parotid gland is mostly caused by squamous cell carcinoma. Despite combined treatment modalities long-term survival remains poor.
aDepartment of Otorhinolaryngology–Head and Neck Surgery, University of Bern, Inselspital, Berne, Switzerland
bDepartment of Pathology, University of Bern, Berne, Switzerland.
Reprint requests: M. Nuyens, MD, Department of Otorhinolaryngology–Head and Neck Surgery, University of Bern, Inselspital, Freiburgstrasse, 3010 Berne, Switzerland.
ABSTRACT